Eric A. Wang

503 total citations
14 papers, 331 citations indexed

About

Eric A. Wang is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Eric A. Wang has authored 14 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Eric A. Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Eric A. Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Eric A. Wang collaborates with scholars based in United States, United Kingdom and India. Eric A. Wang's co-authors include Andrew S. Kennedy, Michael Cohn, Alain Drooz, Charles Nutting, Steven C. Rose, Michael A. Savin, Eduardo Ehrenwald, Douglas M. Coldwell, Steven J. Cohen and Sabine Schirm and has published in prestigious journals such as Radiology, American Journal of Roentgenology and BMC Cancer.

In The Last Decade

Eric A. Wang

14 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric A. Wang United States 12 172 147 129 91 75 14 331
Jennifer A. Shannon Australia 5 196 1.1× 150 1.0× 124 1.0× 119 1.3× 53 0.7× 10 317
Franco Lugnani Italy 11 50 0.3× 49 0.3× 367 2.8× 108 1.2× 25 0.3× 34 519
Yann Lachenal Switzerland 6 421 2.4× 69 0.5× 134 1.0× 144 1.6× 49 0.7× 9 549
Simone Gusmini Italy 10 100 0.6× 127 0.9× 181 1.4× 216 2.4× 58 0.8× 25 399
T. Kim Japan 10 184 1.1× 72 0.5× 63 0.5× 84 0.9× 128 1.7× 17 365
Mine Araz Türkiye 9 21 0.1× 111 0.8× 139 1.1× 95 1.0× 133 1.8× 63 337
Ryan Neff United States 4 15 0.1× 95 0.6× 81 0.6× 76 0.8× 89 1.2× 6 318
M. Barsoum Egypt 7 244 1.4× 185 1.3× 125 1.0× 146 1.6× 65 0.9× 14 490
Ana L. Keppke United States 9 167 1.0× 213 1.4× 105 0.8× 197 2.2× 152 2.0× 10 467
Anne Hong Australia 9 19 0.1× 97 0.7× 142 1.1× 76 0.8× 38 0.5× 25 278

Countries citing papers authored by Eric A. Wang

Since Specialization
Citations

This map shows the geographic impact of Eric A. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Wang more than expected).

Fields of papers citing papers by Eric A. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Wang. The network helps show where Eric A. Wang may publish in the future.

Co-authorship network of co-authors of Eric A. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Wang. A scholar is included among the top collaborators of Eric A. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Wang. Eric A. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Du, Liping, Lea Matsuoka, Daniel Y. Sze, et al.. (2022). Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry. Journal of Vascular and Interventional Radiology. 34(4). 694–701.e3. 13 indexed citations
3.
Du, Liping, Ripal Gandhi, Zachary Collins, et al.. (2022). Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry. Radiology. 305(1). 228–236. 18 indexed citations
4.
Wang, Eric A., et al.. (2017). Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma. Journal of Gastrointestinal Oncology. 8(2). 266–278. 27 indexed citations
5.
Kennedy, Andrew S., Michael Cohn, Douglas M. Coldwell, et al.. (2017). Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases. Journal of Gastrointestinal Oncology. 8(4). 614–624. 39 indexed citations
6.
Wang, Eric A., et al.. (2017). Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. International Journal of Clinical Practice. 71(11). e12972–e12972. 42 indexed citations
7.
8.
Kennedy, Andrew S., David S. Ball, Steven J. Cohen, et al.. (2015). Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer. Clinical Colorectal Cancer. 15(2). 141–151.e6. 12 indexed citations
9.
10.
11.
Wang, Eric A., et al.. (2004). Iatrogenic Left Iliac–Caval Fistula: Imaging and Endovascular Treatment. American Journal of Roentgenology. 183(4). 1032–1034. 14 indexed citations
12.
Civelek, A. Cahid, et al.. (2001). Asymptomatic large main pulmonary artery thromboembolism with a low-probability ventilation-perfusion lung scan.. Clinical Nuclear Medicine. 26(3). 216–220. 1 indexed citations
13.
Wang, Eric A., et al.. (1999). Indium-111 Pentetreotide Scintigraphy of Mesenchymal Tumor With Oncogenic Osteomalacia. Clinical Nuclear Medicine. 24(2). 130–131. 50 indexed citations
14.
Wang, Eric A., et al.. (1999). Multiple Endocrine Neoplasia Type 1: Scintigraphic and Magnetic Resonance Demonstration. Clinical Nuclear Medicine. 24(1). 73–74. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer A. Shannon Breakdown of academic impact, for papers by Franco Lugnani Breakdown of academic impact, for papers by Yann Lachenal Breakdown of academic impact, for papers by Simone Gusmini Breakdown of academic impact, for papers by T. Kim Breakdown of academic impact, for papers by Mine Araz Breakdown of academic impact, for papers by Ryan Neff Breakdown of academic impact, for papers by M. Barsoum Breakdown of academic impact, for papers by Ana L. Keppke Breakdown of academic impact, for papers by Anne Hong
Rankless by CCL
2026